HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Open

BrancheFinanzen

210.4 3.34

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

204

Max

210.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

-34M

71M

Verkäufe

85M

1.3B

KGV

Branchendurchschnitt

29.8

22.989

EPS

0.08

Dividendenrendite

3.47

Gewinnspanne

5.575

Angestellte

10,910

EBITDA

57M

338M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+44.01% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

3.47%

4.69%

Nächstes Ergebnis

4. Aug. 2026

Nächstes Ex-Dividendendatum

20. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-793M

4.1B

Vorheriger Eröffnungskurs

207.06

Vorheriger Schlusskurs

210.4

Nachrichtenstimmung

By Acuity

50%

50%

157 / 439 Ranking in Finance

ConvaTec Group PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Über ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat